CLINICAL_TRIALS
trial_result
· 2017-09-18
Clinical Trial Update: Black Widow Spider Antivenin for Patients With Systemic Latrodectism [Phase 3]
Summary
Phase 3 trial update evaluating a Black Widow spider antivenin for systemic latrodectism; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Latrodectism | Phase 3 | Status: COMPLETED | Results posted: 2017-09-18